Skip to main content
Signal8

Miller Ann Calby

SEC insider (Form 3/4/5 filer). CIK 0001771423. Director at INOVIO PHARMACEUTICALS, INC. (INO). 3 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in PLYMOUTH MEETING, PA.

Companies Miller Ann Calby has filed insider reports for

  • INOVIO PHARMACEUTICALS, INC. (INO): Director
Miller Ann Calby profile photo

Miller Ann Calby

CIK: 0001771423

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INOVIO PHARMACEUTICALS, INC. logo
INO

INOVIO PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • INOVIO PHARMACEUTICALS, INC. logo
    INO

    INOVIO PHARMACEUTICALS, INC.

    May 20, 2026
    Award

    Common Stock Options

    Direct
    41.8K shares-
  • INOVIO PHARMACEUTICALS, INC. logo
    INO

    INOVIO PHARMACEUTICALS, INC.

    May 20, 2026
    Award

    Restricted Stock Unit

    Direct
    34.2K shares-
  • INOVIO PHARMACEUTICALS, INC. logo
    INO

    INOVIO PHARMACEUTICALS, INC.

    May 21, 2025
    Exercise
    Direct
    2.2K shares-

1-3 of 3